Effectiveness of infliximab treatment of complex idiopathic anal fistulas

CONCLUSIONS: Infliximab treatment may be considered a supplement to repeated curettage and setondrainage in the management of selected, complex idiopathic anal fistulas. Such combined treatment may make otherwise refractory fistulas amenable to definitive closure attempts.PMID:33617372 | DOI:10.1080/00365521.2021.1879246

Source: Scandinavian Journal of Gastroenterology - February 22, 2021 Category: Gastroenterology Authors: Anders Dige Andreas Nordholm-Carstensen Kikke Hagen Helene Tarri Hougaard Klaus Krogh J ørgen Agnholt Bodil Ginnerup Pedersen Lilli Lundby Source Type: research